Pursuant to a special resolution passed by shareholders on June 24, 2026, the company has changed its name as follows. There is no consolidation of capital.

Effective at the opening on Tuesday, June 30, 2026, the common shares of Grey Wolf Health Corp. will commence trading on the TSX Venture Exchange and the common shares of Grey Wolf Animal Health Corp. will be delisted. The company is classified as a pharmaceuticals and pharmacy supplies wholesaler -- distributors company.

Capitalization:  unlimited shares with no par value, of which 34,640,294 shares are issued and outstanding

Escrow:  nil shares

Transfer agent:  TSX Trust Company

Trading symbol:  WOLF (unchanged)

Cusip No.:  39788G 10 0 (new)